GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 02/09/2011
PIL Tyverb

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 30/06/2011 and displayed until 02/09/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 03/12/2010 and displayed until 30/06/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 31/08/2010 and displayed until 03/12/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 13/08/2010 and displayed until 31/08/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 28/06/2010 and displayed until 13/08/2010
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 17/11/2009 and displayed until 28/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 16/06/2008 and displayed until 17/11/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   lapatinib ditosylate monohydrate